🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Men diagnosed with significant cancer confined to the prostate currently un...
Status
Completed
Location
King's College Hospital NHS Foundation Trust
Start Date
2019-12-11
Trial ID
NCT04049747
Research on personality disorders (PDs) in older adults is currently limite...
Status
Recruiting
Location
Alexianen Zorggroep Tienen
Start Date
2022-09-01
Trial ID
NCT05548946
The goal of this clinical study is to learn more about the study drug, GS-4...
Status
Recruiting
Location
Qps-Mra, Llc.
Start Date
2024-08-28
Trial ID
NCT06562907
Treatments Being Tested
This will be the first study to investigate the use of rTMS in the treatmen...
Status
Completed
Location
University of Arkansas For Medical Sciences
Start Date
2016-01-01
Trial ID
NCT02608463
Treatments Being Tested
Parts A and B of this study are designed to evaluate the safety, tolerabili...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01852604
The purpose of this study is to learn more about the potential effects of v...
Status
Completed
Location
New York University School of Medicine
Start Date
2015-09
Trial ID
NCT02663921
Treatments Being Tested
The purpose of this study is to assess antiviral activity when administered...
Status
Completed
Location
Gastrointestinal Specialists of Georgia PC
Start Date
2009-04
Trial ID
NCT00911963
Treatments Being Tested
The main objective of antiviral therapy of patients with chronic hepatitis ...
Status
Completed
Location
National Liver Institute
Start Date
2010-09
Trial ID
NCT01197157
Treatments Being Tested
This is a global Phase III, two-arm, open-label, multicenter, randomized st...
Status
Completed
Location
Maryland Oncology Hematology
Start Date
2018-06-14
Trial ID
NCT03493854
This phase I/Ib trial evaluates the best dose and side effects of ipilimuma...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-07-14
Trial ID
NCT04781855
Treatments Being Tested